The TIGIT catastrophe‼️
30 agents
220 trials
~50,000 patients
>$3B+ invested
0 approvals.
This is herding in drug development.
In BMJ Oncol we examine why it happens, the hidden costs, and what needs to change.
It’s already happening again in ADCs...
🔗: t.co/dvbS49jGkF
